BCYC Spring Season Kicks Off! - Bicycle Coalition of Greater Philadelphia
3 weeks ago • Google News
Bicycle Therapeutics Ltd (BCYC)
US$ 8.11991.37%
Price Chart
Key Statistics
Market Cap
$ 597.66M
P/E Ratio
0.00
Revenue (TTM)
$ 25.72M
Volume
283.53K
52W High
$ 28.67
52W Low
$ 6.10
Dividend Yield
0.00%
Beta
1.60
Technicals
50-Day MA
8.3964
200-Day MA
16.655
52 Week High
28.6701
52 Week Low
6.1
About BCYC
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom..
Employees
305
Headquarters
Cambridge, United Kingdom
CEO
Dr. Kevin Lee M.B.A., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg